Staphylococcus aureus (S. aureus) is notorious for its ability to acquire antibiotic-resistance, and antibiotic-resistant S. aureus has become a wide-spread cause of high mortality rate. Novel antimicrobials capable of eradicating S. aureus cells including antibiotic-resistant ones are thus highly desired. Membrane-active bactericides and species-specific antimicrobials are two promising sources of novel anti-infective agents for fighting against bacterial antibiotic-resistance. We herein show that Ca 2+ and Mg 2+ , two alkaline-earth-metal ions physiologically essential for diverse living organisms, both disrupt model S. aureus membranes and kill stationary-phase S. aureus cells, indicative of membrane-activity. In contrast to S. aureus, Escherichia coli and Bacillus subtilis exhibit unaffected survival after similar treatment with these two cations, indicative of species-specific activity against S. aureus. Moreover, neither Ca 2+ nor Mg 2+ lyses mouse red blood cells, indicative of hemo-compatibility. This works suggests that Ca 2+ and Mg 2+ may have implications in targeted eradication of S. aureus pathogen including the antibiotic-resistant ones.
) physiologically essential to almost all living organisms 48 . Upon binding with cardiolipin (CL), a major lipid component in S. aureus membranes 49, 50 , M 2+ (M = Ca, Mg) forms M 2+ -CL complexes of negative curvature (Fig. 1a ) 41, 51 , and negative curvature is a physical parameter necessary for a variety of membrane-destabilization processes as has been validated for those induced by AMPs and SMAMPs 11, [39] [40] [41] [42] . We therefore hypothesize that Ca 2+ and Mg 2+ may be membrane-active, species-specific agent against S. aureus. To test this hypothesis, we perform vesicle membrane permeabilization assays and antibacterial assays and find that, at ≤40 mM, both Ca 2+ and Mg 2+ disrupt model S. aureus membranes and kill stationary phase S. aureus cells, indicative of membrane-activity. In contrast to S. aureus, Escherichia coli and Bacillus subtilis exhibit unaffected survival after similar treatment with these two cations, indicative of species-specific activity against S. aureus. Moreover, within the tested dose range, neither Ca 2+ nor Mg 2+ is hemolytic against mouse red blood cells, indicative of good hemo-compatibility. Collectively, these results suggest that Ca 2+ and Mg 2+ may have implications in targeted eradication of S. aureus pathogen including antibiotic-resistant ones.
Results and Discussion
M 2+ (M = Ca, Mg) binds with CL to form M 2+ -CL complexes of negative curvature (Fig. 1a ) 41, 51 , and negative curvature promote membrane destabilization as validated for cases with AMPs and SMAMPs 11, [39] [40] [41] [42] . We hence evaluated whether Ca 2+ and Mg 2+ destabilizes S. aureus membranes, using mono-component large unilamellar vesicles (LUVs) composed of CL as our first order model of S. aureus membranes and performing dye leakage assays 39, 41, [52] [53] [54] [55] [56] [57] . To dissect the effect of M 2+ dose from those of ionic strength and osmolarity, we use M 2+ -supplemented HEPES buffers (Table 1) which have ionic strength and osmolarity kept almost constant but varying MCl 2 concentration; these same buffers are used for all experiments throughout this work. The first dye probe we used is carboxyl fluorescein (CF), a membrane-impermeant molecule with a hydrodynamic diameter of ~1 nm and negatively charges at physiological pH [58] [59] [60] [61] [62] . Mg 2+ , once ≥ 7.2 mM, caused ~100% CF leakage from CL LUVs (Fig. 1b) , indicative of Mg 2+ -induced CF efflux across CL membranes. Ca 2+ , though unable to cause appreciable CF leakage up to 40 mM (Fig. 1c) , induced >30% lucigenin quenching (Fig. 1d) once ≥20 mM in similar assays but with CF being replaced with lucigenin-a membrane-impermeant, fluorescent Cl − -indicator of similar molecular diameter as CF [63] [64] [65] 57 and perform similar CF leakage assays as above. From DOPG:CL = 58:42 LUVs, Ca 2+ at ≥10 mM caused >90% CF leakage within 300 s after its addition, as compared to undetectable CF leakage caused by that at 5 mM (Fig. 2a) , indicative of a minimum threshold Ca 2+ concentration of 10 mM. Similarly, Mg 2+ at ≥20 mM caused ≥40% CF leakage at 700 s after its addition, as compared to undetectable CF leakage by that at ≤10 mM (Fig. 2b) by performing antibacterial plate killing assays. Note that bacterial cells in stationary phase are more resistant to environmental stresses and antibiotics than counterparts in logarithmic phase 12, 66, 67 . We hence used S. aureus cells in stationary phase, rather than those in logarithmic phase as normally do, for antibacterial assays. Our results (Fig. 3a) a HEPES, NaCl, and sucrose were supplemented to help keep the pH, final ionic strength and final osmolarity constant at 7.4, 170 mM, and 325-340 RT (where R is the gas constant and T is ambient temperature, and ideal solutions are assumed), respectively. Same buffers were used for all experiments through this work unless specified otherwise. (Fig. 3a) , which correlate well with the respective minimal threshold M 2+ dose for these two cations to induce appreciable CF release from model S. aureus membranes (Fig. 2a,b) , suggesting that Ca 2+ and Mg 2+ may kill S. aureus cells by disrupting their membranes.
In stark contrast to their definitive activity against S. aureus, Ca 2+ and Mg 2+ barely affect the viability of E. coli or B. subtilis (Fig. 3b,c) With species-specific antibacterial activity, MCl 2 solutions are distinct from their corresponding MO powder slurries, which are wide-spectrum disinfectants [69] [70] [71] [72] [73] used by human population of different cultures. Moreover, the observed activity of MCl 2 solutions suggests that M 2+ (M = Ca, Mg) ions may play contributive, rather than negligible, roles in the activity of their corresponding metal oxide (MO) powder slurries against S. aureus. To inhibit/kill ≥50% inoculated cells requires MO powder slurries of MO power dose at a few mg/mL, which corresponds to 1-100 mM 70, 71, 74, 75 . Frequently, M 2+ (M = Ca, Mg) ions produced via MO dissociation are viewed as negligible factors in the antibacterial activities of MO powder slurries 74, 76, 77 , due to inactivity of both the supernatant of MgO powder slurry and the MCl 2 solutions at concentrations 10-fold of the MO powder solubility values 70, 72 . Note that M 2+ concentrations even 10-fold of MO powder solubility values are still <10 mM, which is within the barely-active dose range (Fig. 3a) concentrations into the bactericidal range. As potential antimicrobial agents, toxicity to host cells is a major concern. To preliminarily evaluate the toxicity of Mg 2+ and Ca 2+ ions, we performed hemolytic assays against mouse red blood cells. Within the tested concentration range (0-40 mM), neither Mg 2+ nor Ca 2+ caused >5% hemolysis (Fig. 4) , indicative of good hemo-compatibility. Combined with the antibacterial assays (Fig. 3) 
Methods

Materials. S. aureus (ATCC 25923), E. coli (ATCC 25922) and B. subtilis (ATCC 6051) were purchased from
American Type Culture Collection (ATCC) (Virginia, USA). Lipids used in this work, DOPG (1,2-dioleoyl-snglycero-3-[phospho-rac-(1-glycerol)] (sodium salt)), and TOCL (1,1′,2,2′-Tetraoleoyl Cardiolipin, Sodium Salt) were purchased from Avanti Polar Lipids (Alabama, USA) and used without further purification. Carboxyl fluorescein (CF) was purchased from Sigmal-Aldrich (Shanghai, China). Dehydrated Mueller-Hinton (MH) medium formulation and dehydrated Tryptic Soy Broth (TSB) medium formulation were purchased from Qingdao Hope Bio-Technology (Qingdao, China). All other reagents were purchased from Sinopharm Chemical Reagent Company (Shanghai, China). All reagents were used as supplied unless specified otherwise.
Large Unilamellar Vesicle (LUV) Preparations. LUVs composed of 100% CL and DOPG:CL = 58:42 were used as model cellular membranes for S. aureus 57 and prepared via extrusion. Into a glass vial, CL stock solution was added with or without stock solutions of DOPG; all lipid stock solutions were in chloroform at 20 mg/ mL. The resulting lipid mixture was dried under gentle N 2 flow, desiccated in vacuum overnight, and rehydrated with CF (40 mM CF) or lucigenin (1 mM lucigenin, 50 mM NaNO 3 ) solutions at 45 °C for 2 h. The resultant solution was subjected to five freeze-thaw cycles and subsequently extruded through a 0.4-μm Nucleopore polycarbonate membrane (Whatman) for 21 times using a mini-extruder (Avanti Polar Lipids). External CF or lucigenin was removed by gel filtration (Sephadex G-25, GE healthcare) using HEPES buffer A (10 mM HEPES, 150 mM NaCl, pH = 7.4) as eluent.
Characterizations on Membrane-Permeabilization. Fluorescence emission intensity I t for CF (λ ex = 492 nm, λ em = 518 nm) was monitored as a function of time (t). Into a fluorimeter sample cuvette, we added expected CF-preloaded LUV suspension (900 μL) and, at 200 s after initiation of I t recording, M 2+ -containing HEPES solutions (1800 μL in total, Table 1 ), to a final lipid concentration of 0.1 mM. At 900 s after initiation of I t recording (i.e., at 700 s after M 2+ addition), 50 μL 10% triton was added, to yield I ∞ which indicates 100% CF leakage. The percentages of CF leakage were calculated as leakage (%) = (I t − I 0 )/(I ∞ − I 0 ) × 100, where I 0 is the Antibacterial Assays. The antibacterial activities of Ca 2+ and Mg 2+ were evaluated by performing classic plate killing assays against stationary-phase bacterial cells. For each bacterial strain, 3-5 individual bacterial colonies were inoculated into fresh sterile trypticase soy broth (TSB) and incubated at 37 °C with shaking (200 rpm) for 16 h to stationary phase. Bacterial cells were then harvested and washed twice with sterile HEPES buffer A (10 mM HEPES, 150 mM NaCl, pH 7.4) via centrifugation (2,500 rpm, Eppendorf 5810R) for 1 min and, within 15 min, adjusted with sterile HEPES buffer A (10 mM HEPES, 150 mM NaCl, pH 7.4) to ~1.5 × 10 6 CFU/mL and inoculated (50 μL) into each zero-dilution well (150 μL in total) of a preset 96-well microplate.
Expected amounts of divalent cation stock solutions (10 mM HEPES, 150 mM CaCl 2 or MgCl 2 , pH 7.4), sucrose stock solution (10 mM HEPES, 400 mM sucrose, pH 7.4), NaCl stock solution (10 mM HEPES, 500 mM NaCl, pH 7.4), and HEPES buffer B (10 mM HEPES, pH 7.4) were added into each zero-dilution well of a 96-well plate; all solutions were sterilized via filtering. After bacterial inoculation, final inculum size in each zero-dilution well was ~5 × 10 5 CFU/mL and final buffer compositions in the zero-dilution wells are summarized in Table 1 . The microplate was then incubated at 37 °C with shaking (200 rpm) for 40 min. Serial 10-fold dilutions were subsequently made with sterile HEPES buffer A (10 mM HEPES, 150 mM NaCl, pH 7.4). Each dilution (20 μL) was plated onto MH agar plates, which were then incubated at 37 °C overnight to give visible colonies. Inoculum size was indicated by control samples containing untreated bacteria. Each trial was performed in triplicate, and the reported results are the averages of two independent trials. Hemolysis assays. Mouse blood was withdrawn from healthy mice obtained from the Animal Center of Anhui Medical University; the animal treatment was performed in compliance with the guidelines for the care and use of research animals established by the Animal Care and Use Committee at University of Science and Technology of China, and the experimental protocol was approved by the Animal Care and Use Committee at University of Science and Technology of China. Fresh mouse blood (200 μ L) was washed with sterile HEPES buffer (10 mM HEPES, 150 mM NaCl, pH = 7.4) (800 μ L) and washed for three times with sterile HEPES buffer via centrifuge at 900 rcf for 5 min, and the pellet was re-suspended into sterile HEPES buffer (1,000 μ L) to yield the mouse red blood cell (mRBC) stock suspension for hemolysis assays. The mRBC stock suspension (200 μ L) and MCl 2 -containing HEPES solution (400 μ L) were added into each centrifuge cups. After the incubation at 37 °C for 40 min with shaking at 250 rpm, the centrifuge cups were centrifuged at 900 rcf for 5 min, and the supernatant (100 μ L) of each cup was transferred into a well of a 96-well microplate. Hemolysis was monitored by measuring the absorbance of the released hemoglobin at optical density at 414 nm, OD 414 . Controls included HEPES buffer (300 μ L) and mRBC suspension (200 μ L) treated with triton X-100 (50%, 100 μ L) to provide reference for 0% and 100% hemolysis, respectively. Each hemolysis assay trial was carried out in triplicate, and the reported results are the averages of two independent trials. Statistical Analysis. Statistical comparisons were carried out by performing student t test analysis with the statistical software package BioMedCalc (version 2.9). p values of <0.05 and <0.01 indicate statistical difference and statistically significant difference, respectively.
